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Diffusion tensor imaging with direct
cytopathological validation: characterisation
of decorin treatment in experimental juvenile
communicating hydrocephalus
Anuriti Aojula1,2,5†, Hannah Botfield1,2,5†, James Patterson McAllister II3*‡ , Ana Maria Gonzalez1,5,
Osama Abdullah4, Ann Logan4,5 and Alexandra Sinclair1,2,5,6‡

Abstract
Background: In an effort to develop novel treatments for communicating hydrocephalus, we have shown previously
that the transforming growth factor-β antagonist, decorin, inhibits subarachnoid fibrosis mediated ventriculomegaly;
however decorin’s ability to prevent cerebral cytopathology in communicating hydrocephalus has not been fully
examined. Furthermore, the capacity for diffusion tensor imaging to act as a proxy measure of cerebral pathology in
multiple sclerosis and spinal cord injury has recently been demonstrated. However, the use of diffusion tensor imaging to investigate cytopathological changes in communicating hydrocephalus is yet to occur. Hence, this study aimed
to determine whether decorin treatment influences alterations in diffusion tensor imaging parameters and cytopathology in experimental communicating hydrocephalus. Moreover, the study also explored whether diffusion tensor
imaging parameters correlate with cellular pathology in communicating hydrocephalus.
Methods: Accordingly, communicating hydrocephalus was induced by injecting kaolin into the basal cisterns in
3-week old rats followed immediately by 14 days of continuous intraventricular delivery of either human recombinant
decorin (n = 5) or vehicle (n = 6). Four rats remained as intact controls and a further four rats served as kaolin only
controls. At 14-days post-kaolin, just prior to sacrifice, routine magnetic resonance imaging and magnetic resonance
diffusion tensor imaging was conducted and the mean diffusivity, fractional anisotropy, radial and axial diffusivity of
seven cerebral regions were assessed by voxel-based analysis in the corpus callosum, periventricular white matter,
caudal internal capsule, CA1 hippocampus, and outer and inner parietal cortex. Myelin integrity, gliosis and aquaporin-4 levels were evaluated by post-mortem immunohistochemistry in the CA3 hippocampus and in the caudal
brain of the same cerebral structures analysed by diffusion tensor imaging.
Results: Decorin significantly decreased myelin damage in the caudal internal capsule and prevented caudal periventricular white matter oedema and astrogliosis. Furthermore, decorin treatment prevented the increase in caudal
periventricular white matter mean diffusivity (p = 0.032) as well as caudal corpus callosum axial diffusivity (p = 0.004)
and radial diffusivity (p = 0.034). Furthermore, diffusion tensor imaging parameters correlated primarily with periventricular white matter astrocyte and aquaporin-4 levels.
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Conclusions: Overall, these findings suggest that decorin has the therapeutic potential to reduce white matter
cytopathology in hydrocephalus. Moreover, diffusion tensor imaging is a useful tool to provide surrogate measures of
periventricular white matter pathology in communicating hydrocephalus.
Keywords: Hydrocephalus, DTI, Cytopathology, Decorin

Background
Hydrocephalus is a common paediatric neurosurgical
presentation with an incidence of 0.48–0.81 per 1000
live births [1–3]. Communicating hydrocephalus is aetiologically heterogeneous; bacterial meningitis, subarachnoid haemorrhage, trauma, intracranial and intraspinal
tumours as well as leptomeningeal metastases can all
cause the disorder [4–10]. The incidence of communicating hydrocephalus following subarachnoid haemorrhage
is at least 13 % and can be as high as 67 % [11]. In addition to ventriculomegaly, communicating hydrocephalus
is accompanied by extensive global cerebral pathology,
including widespread reactive gliosis, hydrocephalic
oedema and demyelination [10, 12].
Although shunting is the current standard of care for
children with hydrocephalus, the procedure is associated with severe complications that contribute to an
increased patient morbidity [13–16]. Furthermore, academic attainment and social integration difficulties continue into adulthood for those with the disease [17–19].
Therefore, the development of novel therapeutic strategies to prevent the development of hydrocephalus or
promote recovery is of critical importance. Our recent
study (Additional file 1: Figure S1) supports the key role
of transforming growth factor-beta (TGF-β) in communicating hydrocephalus, as decorin, a TGF-β antagonist
[20–23] ameliorated subarachnoid fibrosis and therefore
significantly attenuated the enlargement of the ventricular system [12]. However, the effectiveness of decorin
to prevent cytopathology in hydrocephalus is yet to be
examined thoroughly. Given that cellular pathology is
largely responsible for the array of functional deficits
observed clinically and contributes to the impairment
in patient health-related quality of life, it is important to
understand whether decorin can attenuate these alterations in vivo [10, 24, 25].
Greater insight into the cytopathological changes
occurring in communicating hydrocephalus can be
achieved with the use of advanced non-invasive magnetic
resonance diffusion tensor imaging (DTI) [26]. DTI is a
specialised magnetic resonance imaging (MRI) technique
that examines tissue anisotropic properties and cerebral microstructural integrity [27, 28]. DTI yields a set
of quantitative metrics, reflecting the magnitude along
the principal axes of water diffusion, which are sensitive to changes in the underlying brain microstructure.

Commonly used scalar DTI parameters such as axial
(AD), radial (RD), and mean diffusivities (MD) (equivalent to the speed of motion in the principal axes of diffusion) or the fractional anisotropy (FA) (equivalent to a
normalized aspect ratio of the principal axes of diffusion)
have been useful in the investigation of cerebral abnormalities; an increase in the AD, RD and MD alongside a
decrease in the FA occurs in the cerebral white matter
of children with hydrocephalus [29–33]. Furthermore,
the specificity of DTI to act as a surrogate measure of
cerebral pathology has been highlighted in a variety
of conditions, including hypoxic ischaemic injury [34,
35], multiple sclerosis [36–39], spinal cord injury [40],
obstructive hydrocephalus [41], temporal lobe epilepsy
[42, 43] and for delineating gliomas [44]. However, correlations between DTI parameters and underlying cytopathology in communicating hydrocephalus have yet to
be determined (Appendix 1).
Therefore, using immunohistochemistry and clinically
relevant neuroimaging we investigated whether decorin
is able to attenuate damage-related parameters and if cellular changes in communicating hydrocephalus can be
quantitatively characterised by DTI using a juvenile rat
model of the disorder.

Methods
Experimental animals

Three-week-old Sprague–Dawley rats (Charles River,
Massachusetts, USA) were housed in litters in individual cages, kept under a 12 h light/dark cycle with free
access to food and water. Animals were monitored for
adverse effects of treatments, such as distress, lethargy,
weight loss and seizures, and any animals showing severe
adverse effects were euthanised. Experiments were conducted at the University of Utah in accordance with the
guidelines of the National Institutes of Health Care and
Use of Laboratory Animals and approved by the University of Utah Ethics Committee.
Experimental design and surgical techniques

The experimental design and surgical techniques are
described in detail elsewhere [12]. Using a ventral
approach, the interval between the occipital bone and
the C-1 vertebral body was exposed and a 30 gauge
angled needle was inserted into the prepontine (basal cistern) subarachnoid space. 30 µl of 20 % kaolin solution
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(200 mg/ml in 0.9 % sterile saline; Fisher Scientific, Massachusetts, USA) was injected to induce communicating hydrocephalus and the rat was either allowed to
recover or underwent osmotic pump and intraventricular cannula implantations. The cannulae were inserted
into the right lateral ventricle and fixed in place with
glue and bone cement (Biomet UK Ltd, Bridgend, UK)
to a stabilising screw, and connected to subcutaneously
implanted mini osmotic pumps. Osmotic pumps (model
2002 adapted for use in MRI scanners with PEEK tubing, Alzet, Durect Corporation, California, USA) were
filled with either 5 mg/ml human recombinant decorin
(GalacorinTM, Catalent/Pharma Solutions, New Jersey,
USA) or 10 mM phosphate buffered saline (PBS) pH 7.4
(Sigma-Aldrich, Missouri, USA). Over the subsequent
14 days, human recombinant decorin was infused at a
rate of 2.5 mg/0.5 ml/h.
Rats were randomly assigned to four groups: (1) Intact
age-matched controls (Intact group, n = 4); (2) basal
cistern kaolin injections only (kaolin group, n = 4); (3)
kaolin injection with intraventricular infusion of PBS
(kaolin + PBS group; n = 6); and (4) kaolin injection with
intraventricular infusion of decorin (kaolin + decorin
group; n = 5). Magnetic resonance imaging (MRI) and
diffusion tensor imaging (DTI) were conducted after
14 days of treatment to assess the extent of hydrocephalus before sacrifice, then the brains were removed and
processed for histology.
Magnetic resonance imaging and diffusion tensor imaging

Imaging experiments were conducted 14 days post injury
using a 7-Tesla horizontal-bore Bruker Biospec MRI
scanner (Bruker Biospin, Ettlingen, MA, USA) interfaced
with a 12-cm actively shielded gradient insert capable of
producing magnetic field gradient up to 600 mT/m. Animals were anesthetised using 1–3 % Isoflurane and 0.8 L/
min O2 and their vital signs (respiration, temperature,
heart rate and oxygen saturation percentage) were continuously monitored using a MR-compatible physiological monitoring system (SA Instruments, Stony Brook,
NY, USA). Animals were placed in a 72-mm volume coil
for signal transmission, and a quadrature surface coil was
placed on the head for signal reception. Acquisition of
T2-weighted MRI scans and ventricular volume analysis
has been described previously [12]. DTI scans were conducted using spin echo diffusion-weighted sequences
with single-shot EPI readout, with the following parameters (TR of 3760 ms, TE of 44 ms, 15 coronal 1 mm-thick
slices, a field of view of 2.5 × 2.5 cm, and an in-plane resolution of 195 × 195 µm). Thirty uniformly-spaced over
unit sphere diffusion-weighted gradient directions and
five non-weighted images were acquired with two signal
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averages and the following diffusion parameters: diffusion gradient duration 7 ms, separation 20 ms, diffusion
encoding sensitivity 700 s/mm2. Scan time was 4 min. For
ventriculomegaly analysis, one MRI scan image was chosen from the rostral cerebrum (−0.36 mm from bregma)
and the caudal cerebrum (−3.72 mm from bregma) for
each rat, and the ventricular area was determined in each
scan using ImageJ.
DTI voxel based analysis

Prior to commencing voxel-based analysis, double blinding was introduced to prevent group identification.
Using the software, DSI Studio (DSI Studio, Pittsburgh,
PA), DTI images were reconstructed and processed to
produce voxel based maps, from which regions of interest (ROIs) could be analysed. The seven ROIs selected
include: corpus callosum, periventricular white matter,
caudal and rostral internal capsule, outer parietal cortex,
inner parietal cortex and CA1 hippocampus. DTI parameter values from four serial sections (1.28 mm anterior to
Bregma to 3.72 mm posterior to Bregma) of the corpus
callosum and periventricular white matter were analysed
in a total of 17 rats [Intact (n = 4), kaolin (n = 4), kaolin + PBS (n = 5), kaolin + decorin (n = 4)]. The rostral
corpus callosum and periventricular white matter sections were defined as 1.28 and −0.36 mm from Bregma.
The caudal corpus callosum and periventricular white
matter sections were derived from −2.76 to −3.72 mm
from Bregma (Fig. 2a). The remaining five ROIs were
analysed in 16 rats, with four animals being examined
in each experimental group. Three sections were independently analysed for the CA1, caudal internal capsule,
outer and inner parietal cortex from 0.36 to 3.72 mm
posterior to Bregma. An average of two sections from
1.28 mm anterior to Bregma to 0.36 mm posterior to
Bregma were individually analysed for the rostral internal
capsule. ROIs were identified using a FA voxel based map
and an analogous DTI image (Fig. 1). The mean FA, MD,
AD and RD values were calculated for each ROI of each
animal.
Tissue preparation for histology

Rats were euthanised and immediately perfused transcardially with PBS followed by 4 % paraformaldehyde
(Alfa Aesar, Ward Hill, MA, USA) in PBS. Brains were
immersed in 4 % paraformaldehyde overnight at 4 °C,
cryoprotected by sequential immersion in 10, 20 and
30 % sucrose solutions in PBS at 4 °C and embedded in
optimum cutting temperature embedding matrix (Fisher
Scientific). Subsequent sectioning and staining of the tissue was conducted at the University if Birmingham. Coronal sections 15-µm thick were cut on a Bright cryostat
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Fig. 1 Regions of interest (ROIs) for DTI analysis in each experimental group. Representative voxel based map images and analogous diffusion tensor images of the caudal cerebrum at 2.76 mm posterior to Bregma are shown for the four experimental groups. All ROIs selected for
analysis, except from the rostral internal capsule, are displayed. ROIs were chosen with the aid of a rat brain atlas [45]; white = corpus callosum,
green = periventricular white matter, cyan = outer parietal cortex, yellow = inner parietal cortex, red = CA1 hippocampus, magenta = caudal
internal capsule, scale bar = 100 μm

(Bright Instrument, Huntingdon, UK), serially mounted
and stored at −20 °C before staining.
Antibodies

Myelin integrity was assessed with an antibody against
myelin basic protein (MBP; rat, Merck Millipore, Watford, UK, MAB386). Antibodies against glial fibrillary
acidic protein (GFAP; mouse, Sigma-Aldrich, G3893)
and OX-42 (CD-11b; mouse, Serotec, Kidlington, UK,
MCA527R) were used to assess gliosis and the extent of
oedema resolution was examined by aquaporin-4 (AQP4)
antibody staining (chicken, Genway, San Diego, CA,
USA, 07GA0175-070718).
Fluorescent immunohistochemistry

Immunohistochemistry was conducted on the caudal
cerebrum of 19 rats [Intact (n = 4), kaolin (n = 4), kaolin + PBS (n = 6), kaolin + decorin (n = 5)]. All selected
sections were at least −2.5 mm posterior to Bregma and
corresponded with the location of the DTI sections. Sections were washed in PBST (10 mM PBS pH 7.4 containing 0.3 % Tween20) and blocked in 2 % bovine serum
albumin (BSA) and 15 % normal goat serum in PBST at
room temperature for 1 h. Subsequently, sections were
washed in PBST, before being incubated at 4 °C overnight
in primary antibody diluting buffer containing PBST
and 2 % BSA. After washing in PBST the sections were
incubated for 1 h in secondary antibody solution (Alexa
Fluor® 488 or 594 labelled secondary antibodies (Life
Technologies, Paisley, UK) in PBST with 2 % BSA and
1.5 % normal goat serum) at room temperature, in the
dark. After further PBST washes, sections were mounted
in Vectashield containing DAPI (Vector Laboratories,
Peterborough, UK). The Zeiss Axioplan 2 imaging epifluorescent microscope (Carl Zeiss, Germany) and the AxioCam Hrc (Carl Zeiss, Jena, Germany) were used to view
and capture images under the same conditions for each
antibody at ×400 magnification.

Pixel based analysis of immunofluorescent staining

Quantitative analysis was undertaken using the software, Image J and all analyses were undertaken with the
operator masked to the experimental group. Images for
each immunofluorescent stain were processed identically
before being analysed. For each image analysed, four randomly placed regions of interest (ROIs) were drawn with
each ROI being 2.96 mm wide and 1.57 mm in height.
For the corpus callosum, periventricular white matter
and CA1 and CA3 hippocampal regions, a mean of 16
ROIs (four regions of interest × four coronal sections)
were chosen per rat per stain. An average of 8 ROIs (four
regions × two coronal sections) were selected for the
internal capsule, caudate-putamen, parietal cortex and
occipital cortex. All areas were analysed for GFAP, OX-42
and AQP4 staining however, as MBP is a marker of white
matter integrity, only the corpus callosum, periventricular white matter and internal capsule were analysed for
this antibody.
GFAP and OX-42 image processing included the
conversion of images into a gray scale format prior
to spatial filtering, thresholding and despeckling of
the images using Image J. Images stained for AQP4
and MBP were identically processed to the GFAP and
OX-42 images except thresholding was not performed.
The mean percentage area of GFAP, OX-42, AQP4 and
MBP positive staining, for each experimental group
was calculated.
Bright field microscopy

In order to assess hippocampal size, one cerebral section, at least 2.5 mm posterior to Bregma from each
experimental animal was examined at ×10 magnification
using the Nikon SM21500 dissecting microscope (Nikon,
Tokyo, Japan). Images were captured with a Nikon ds2mv high-resolution camera (Nikon). Hippocampal area
was assessed by using the Image J software analyze area
tool.
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Statistics

Statistical analysis was conducted using SPSS software,
version 22 (IBM, Armonk, NY). Normally distributed
data were analysed using a one-way ANOVA followed
by a post hoc Tukey test. In the absence of normality,
data were analysed using the Kruskal–Wallis test and
tested for significant pairwise comparisons. Normally
distributed data were expressed as the mean ± standard
error of the mean (SEM). Correlation analysis was performed using a two-tailed Spearman’s correlation test.
As immunohistochemistry analysis was performed on
caudal sections, mean DTI data from Section 2.76 and
3.72 mm posterior to Bregma were used for correlation
analysis. Correlation analysis was not undertaken for the
inner parietal cortex, caudate-putamen, occipital cortex
or CA3 region of the hippocampus because DTI analysis was not being performed in these areas. Values were
considered statistically significant when p values were
*p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001.

Results
Decorin reduces hydrocephalus induced DTI changes in the
caudal periventricular white matter and corpus callosum

In the caudal periventricular white matter (−2.76 and
−3.72 mm from Bregma), compared to Intact controls (0.83 ± 0.00 and 1.20 ± 0.02, respectively; Fig. 2b),
the kaolin and kaolin + PBS groups displayed a significant increase in the MD (1.48 ± 0.22, p = 0.023 and
1.56 ± 0.15, p = 0.031 respectively) and AD (2.04 ± 0.27,
p = 0.020 and 2.16 ± 0.17, p = 0.018, respectively). By
contrast, the MD of decorin treated rats (0.85 ± 0.00) was
significantly lower in comparison to kaolin (1.48 ± 0.22,
p = 0.032) and kaolin + PBS (1.56 ± 0.15, p = 0.044)
rats. No significant differences were observed in any
DTI parameters in the rostral periventricular white matter (1.28 and −0.36 mm from Bregma) between the four
experimental groups.
In the caudal corpus callosum (−2.76 and −3.72 mm
from Bregma), the AD for kaolin (1.80 ± 0.15, p = 0.010)
and kaolin + PBS (1.92 ± 0.12, p = 0.001) groups were significantly higher than Intact controls (1.56 ± 0.05; Fig. 2c).
Moreover, kaolin + PBS rats displayed a significant elevation in the MD (1.17 ± 0.08, p = 0.030) and RD (1.00 ± 0.06,
p = 0.025), compared to Intact animals (0.88 ± 0.02 and
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0.54 ± 0.02, respectively). Furthermore, decorin treatment
significantly reduced the AD (1.49 ± 0.02, p = 0.004) and
RD (0.62 ± 0.03, p = 0.034) compared to the kaolin + PBS
animals (1.92 ± 0.12 and 1.00 ± 0.06, respectively) in the
caudal corpus callosum. No significant differences existed
between decorin treated rats and Intact controls for all DTI
parameters in the caudal corpus callosum. Similar to the
rostral periventricular white matter, in the rostral corpus
callosum (1.28 and −0.36 mm from Bregma), there were no
significant differences in the DTI parameters between the
experimental groups.
Alongside the corpus callosum and the periventricular
white matter, five other regions of interest were examined
by DTI voxel based analysis (Additional file 2: Figure S2).
Significant differences in the four DTI parameters were not
observed in the outer or inner parietal cortex (Additional
file 2: Figure S2a, b). However, the FA of the kaolin group
was significantly lower (0.11 ± 0.02, p = 0.036) than Intact
controls (0.16 ± 0.01) in the CA1 region of the hippocampus (Additional file 2: Figure S2c). Moreover, in the caudal internal capsule (Additional file 2: Figure S2d), decorin
(0.83 ± 0.01, p = 0.003) reduced the decrease in the MD
observed in kaolin + PBS animals (0.77 ± 0.00). In the rostral internal capsule (Additional file 2: Figure S2e), kaolin + PBS rats displayed significantly greater FA (0.16 ± 0.01,
p = 0.022) and AD (1.70 ± 0.28, p = 0.039) compared to
Intact controls (0.23 ± 0.00 and 0.68 ± 0.23, respectively).
Ventriculomegaly is greatest in the caudal hydrocephalic
cerebrum and correlates with DTI parameters

As DTI parameter abnormalities were predominantly
observed in the caudal cerebrum, we investigated whether
non-uniform ventriculomegaly occurs in the basal cistern
model of communicating hydrocephalus. In the kaolin
and kaolin + PBS groups, the ventricles expanded significantly (p < 0.05) rostrally (8.04 ± 1.74 and 10.12 ± 3.83
mm3, respectively) and caudally (16.22 ± 2.76 and
21.00 ± 5.43 mm3, respectively) compared to the Intact
controls (rostral = 1.26 ± 0.11 and caudal = 0.93 ± 0.10
mm3). Furthermore, significant changes in the mean differences between the rostral versus caudal ventricular
volume were discovered (Table 1).
Rostrally, ventricular volume significantly correlated with the FA, MD, AD and RD measurements of

(See figure on next page.)
Fig. 2 Decorin reduced hydrocephalus induced abnormalities in the caudal corpus callosum and periventricular white matter as evident from DTI. a
Representative FA images of the locations at which the corpus callosum and periventricular white matter were analysed. Section 1 (1.28 mm anterior
to Bregma) and Section 2 (0.36 mm posterior to Bregma) are classified as the rostral periventricular white matter and corpus callosum. Section 3
(2.76 mm posterior to Bregma) and Section 4 (3.72 mm posterior to Bregma) refer to the caudal periventricular white matter and corpus callosum.
Line graphs displaying decorin’s ability to reduce abnormalities in the (b) corpus callosum and (c) periventricular white matter on DTI; blue = Intact,
green = kaolin, red = kaolin + PBS, orange = kaolin + decorin [Intact (n = 4), kaolin (n = 4), kaolin + PBS (n = 6), kaolin + decorin (n = 5)]. Error bars
represent the standard error of the mean; *p < 0.05, **p < 0.01, ***p < 0.001
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Table 1 Significant changes in the mean differences
between the rostral versus caudal ventricular volumes
amongst the four experimental groups
p
Intact vs Kaolin

0.005

Intact vs Kaolin + PBS

<0.001

Kaolin vs Kaolin + PBS

0.530

Kaolin + PBS vs Kaolin + decorin

0.001

Intact vs Kaolin + decorin

0.946

Kaolin vs Kaolin + decorin

0.015

the corpus callosum and periventricular white matter
(Table 2). Likewise, the caudal ventricular volume correlated with all DTI parameter measures in the corpus callosum and all except the AD in the periventricular white
matter (Table 2).
Decorin reduces caudal periventricular white matter
cytopathology

As DTI parameter abnormalities were observed in the
caudal periventricular white matter, corresponding
immunohistochemistry analysis was conducted to aid

Table 2 DTI parameter values of the corpus callosum
and periventricular white matter correlated with rostral
and caudal ventricular volume
DTI parameter

R (Spearman’s rho)

p

Rostral ventricular volume
CC FA

0.831

<0.001

CC MD

0.539

0.026

CC AD

0.527

0.030

CC RD

0.733

0.001

PVWM FA

0.949

<0.001

PVWM MD

0.706

0.002

PVWM AD

0.507

0.038

PVWM RD

0.642

0.005

Caudal ventricular volume
CC FA
CC MD

−0.676
0.723

0.003
0.001

CC AD

0.777

<0.001

CC RD

0.838

<0.001

PVWM FA
PVWM MD

−0.520
0.537

0.033
0.026

PVWM AD

0.441

0.076

PVWM RD

0.547

0.023

Statistically significant correlations = p < 0.05

CC corpus callosum, PVWM periventricular white matter, FA fractional anisotropy,
MD mean diffusivity, AD axial diffusivity, RD radial diffusivity, R correlation
coefficient (Spearman’s rho)

hydrocephalic cytopathology characterisation of these
tissues. We determined that the levels of GFAP positive
immunostaining (Fig. 3a) were significantly increased
in kaolin rats (2.49 ± 0.23 %, p = 0.048) compared to
Intact controls (0.82 ± 0.11 %) indicating the presence of astrogliosis in the caudal periventricular white
matter. Furthermore, the GFAP positive astrocytes of
hydrocephalic animals exhibited features typical of
reactive astrocytic morphology; cytoplasmic processes
underwent thickening in kaolin and kaolin + PBS rats.
The increase in GFAP positive staining observed in the
kaolin rats (2.49 ± 0.23 %) was prevented with decorin
treatment (0.49 ± 0.11 %, p = 0.002). Additionally, kaolin (1.77 ± 0.14 %, p = 0.040) and kaolin + PBS rats
(1.34 ± 0.29 %, p = 0.056) displayed a significant and
non-significant increase respectively in periventricular
white matter AQP4 positive immunostaining (Fig. 3b)
compared to Intact controls (0.80 ± 0.12 %). Importantly,
AQP4 immunostaining in kaolin + decorin treated rats
was significantly lower (0.56 ± 0.09 %, p = 0.006) than
in kaolin animals (1.77 ± 0.14 %). No significant difference existed in periventricular white matter AQP4
immunostaining between decorin treated and Intact control rats (p = 0.860). In contrast, significant differences
in OX-42 and MBP levels were not present between the
experimental groups in the periventricular white matter
(Fig. 3c, d). Furthermore, significant differences in GFAP,
OX-42, MBP and AQP4 immunostaining were not present between the experimental groups in the caudal corpus callosum (Additional file 3: Table S1).
Decorin protects from myelin damage in the caudal
internal capsule

Although significant differences in myelin levels were not
present in the caudal corpus callosum and caudal periventricular white matter, loss of myelin (assessed by measurement of MBP) in the caudal internal capsule was present
in kaolin and kaolin + PBS animals (Fig. 4); compared to
Intact controls (8.11 ± 0.49 %), a decrease in MBP immunostaining was present in kaolin (3.13 ± 0.28 %, p < 0.001)
and kaolin + PBS (5.15 ± 0.47 %, p = 0.001) rats. Furthermore, decorin treated rats displayed higher MBP
levels (5.87 ± 0.29 %) compared to kaolin (3.13 ± 0.28 %,
p = 0.002) and kaolin + PBS rats (5.15 ± 0.47 %,
p = 0.018), although the levels did not quite reach the
same as in intact rats (p = 0.009), indicating some myelin
protection. Qualitatively, the longitudinal organisation of
myelin was disrupted, with discontinuity present along
the length of the myelin fibres in animals receiving kaolin
and kaolin + PBS compared to Intact controls. The regular parallel arrangement of MBP staining was protected
with decorin treatment.
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(See figure on previous page.)
Fig. 3 Decorin prevented an increase in GFAP and AQP4 in the periventricular white matter. Representative images comparing the level of (a) GFAP
immunostaining (green), (b) AQP4 immunostaining (red), (c) OX-42 immunostaining (green) and (d) MBP immunostaining (green) in the periventricular white matter; scale bar = 10 μm. a kaolin and kaolin + PBS rats displayed thickening of astrocytic processes (white arrow). b Accumulation of
AQP4 staining was observed in kaolin rats (white arrow). AQP4 was further arranged around the circumference of blood vessels (yellow arrow).
c Elongated, amoeboid microglia (yellow arrow) were particularly evident in kaolin rats. Microglia of kaolin + PBS rats were captured transitioning
from branched resting microglia to activated amoeboid microglia (blue arrow). d Decorin treatment improved the myelin loss and disorganisation
present in kaolin and kaolin + PBS rats (white arrow). Each corresponding bar graph displays the mean percentage of GFAP, AQP4, OX-42 or MBP
positive pixels above threshold or background in the periventricular white matter across the four experimental groups; V lateral ventricle, error bars
represent the standard error of the mean, *p < 0.05, **p < 0.01

Decorin attenuates hippocampal atrophy
in communicating hydrocephalus

Upon examining total hippocampal area, significant differences were present between the four experimental
groups; a decrease in normalised hippocampal area was
identified in the kaolin (47 ± 9 %, p = 0.006) and kaolin + PBS rats (69 ± 9 %, p < 0.001) compared to Intact
controls (100 ± 6 %). Decorin treatment attenuated the
hippocampal atrophy (89 ± 7 %, p = 0.008) compared to
kaolin rats but failed to maintain the hippocampal size to
that in Intact controls (100 ± 6 %, p < 0.001). In the CA1
region of the hippocampus, similar levels of GFAP, OX-42
and AQP4 were observed between all the experimental
groups. In the CA3 region, GFAP levels were comparable
among all four groups however kaolin rats (0.43 ± 0.02 %,
p = 0.057) demonstrated a trend towards reduced OX-42
levels compared to Intact controls (0.89 ± 0.03 %), and
kaolin + PBS rats (1.04 ± 0.13 %, p = 0.043) displayed
a significant increase in AQP4 levels compared to Intact
controls (1.60 ± 0.10 %; Additional file 4: Table S2).
GFAP and AQP4 levels correlate significantly in the corpus
callosum, periventricular white matter, caudate‑putamen,
parietal cortex and occipital cortex

No significant differences in AQP4, OX-42 and GFAP
immunostaining were present between the experimental groups in the caudate putamen, parietal cortex and
occipital cortex (Additional file 4: Table S2). However,
in the corpus callosum, periventricular white matter,
caudate-putamen, parietal cortex and occipital cortex,
GFAP immunostaining positively correlated with AQP4
levels (Table 3). No significant correlations were present
between OX-42 and AQP4 levels in any of the regions of
interest.
Hydrocephalic cytopathology correlates
with abnormalities on DTI

In the caudal corpus callosum, increased astrocyte
(GFAP) and AQP4 levels positively correlated with the
AD (Table 4). Furthermore, in the caudal periventricular
white matter (Table 4), GFAP and AQP4 positively correlated with AD, MD and RD. Moreover, the presence of

cytopathology discouraged anisotropic water diffusion in
the caudal periventricular white matter as the FA negatively correlated with astrocyte (GFAP), microglial (OX42) and AQP4 immunostaining. A negative correlation
was also present between myelin levels (MBP) and the
MD of the caudal periventricular white matter.

Discussion
This study demonstrates that decorin is able to protect and maintain DTI parameter values at normality
in the caudal corpus callosum and caudal periventricular white matter. Likewise, decorin prevents astrogliosis
and oedema in the caudal periventricular white matter and preserves myelin integrity in the caudal internal
capsule. Furthermore, cytopathology in communicating
hydrocephalus is predominantly localised to the caudal cerebrum. Moreover, DTI parameters correlate with
cytopathology specifically in the caudal periventricular
white matter. DTI is therefore a useful tool to act as a
surrogate measure of cytopathology in communicating
hydrocephalus.
Recent studies in post-haemorrhagic hydrocephalus
suggest that occipital horn enlargement is greater and
precedes the dilation of the remaining ventricular system
[46–48]. This asymmetry is a pattern that is repeated in
other types of hydrocephalus including congenital hydrocephalus [49] and idiopathic chronic hydrocephalus [50],
although this feature has not been explored in depth or
quantitatively. In feline infants [51], neonatal rats [41, 52]
and adult dogs [53] with non-communicating hydrocephalus induced by kaolin injections into the cisterna magna,
the occipital horns of the lateral ventricles are conspicuously larger than the frontal horns. Our results support
these findings, albeit in an experimental model of communicating hydrocephalus, by showing that caudal portions of the lateral ventricles expand more than frontal
regions, and DTI abnormalities are largely situated in the
caudal white matter.
Asaaf and colleagues [54] suggested that DTI could be
used as a marker of white tissue compression in obstructive hydrocephalus. Furthermore there have been no
observed DTI changes in the white matter of idiopathic
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Fig. 4 Decorin prevented myelin loss in the caudal internal capsule. a Representative images comparing caudal internal capsule MBP immunostaining (green) across the four experimental groups. Myelin organisation was better maintained with decorin use. b A bar graph displaying the
mean percentage of MBP positive pixels above threshold in the internal capsule across the four experimental groups. Decreased MBP levels were
present in kaolin and kaolin + PBS rats which was incompletely attenuated with decorin treatment; error bars represent the standard error of the
mean, *p < 0.05, **p < 0.01, ***p < 0.001; scale bar = 50 μm
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Table 3 AQP4 levels correlated significantly with the
marker of gliosis, GFAP, in the corpus callosum, periventricular white matter, caudate-putamen and parietal
and occipital cortex
p

Table 4 The marker of gliosis, GFAP, and AQP4 levels correlated with DTI parameter values in the periventricular
white matter
ROI

Immunostain DTI parameter R

Corpus callosum

GFAP

p

Region of interest

R

Corpus callosum

0.614

0.005

Periventricular white matter

0.854

<0.001

AD

0.600

0.011*

CA1 hippocampus

0.332

0.166

RD

0.424

0.090*

FA

−0.086

CA3 hippocampus

0.446

0.056

Internal capsule

0.291

0.226

FA
MD

OX-42

MD

−0.370
0.306

0.002

0.144
0.232

0.743
0.993

Caudate-putamen

0.495

0.043

AD

0.352

0.165

Parietal cortex

0.528

0.020

RD

0.120

0.646

Occipital cortex

0.607

0.006

FA

−0.323

AQP4

MD

Statistically significant correlations = p < 0.05
R correlation coefficient

MBP

intracranial hypertension patients (high ICP but no ventriculomegaly [55]) suggesting that compression of tissue
impacts DTI parameters. In the caudal periventricular
white matter, our findings replicate the abnormalities
in the MD, AD and RD observed in hydrocephalic children [29–31]. In contrast to our findings, the MD of the
periventricular white matter does not increase in posthaemorrhagic hydrocephalus in adults [56], therefore
the maturity of the brain appears to influence DTI alterations. Similar to the findings of Yuan et al. [41] in rats of
the same age with obstructive hydrocephalus (blockage of
the cisterna magna), our communicating hydrocephalic
animals display an increase in MD and reduced FA in the
caudal corpus callosum. Our study has also revealed an
increase in the AD and RD of the caudal corpus callosum
in communicating hydrocephalus, which is additionally
preventable by decorin treatment.
The cytopathology observed in our model supports
current literature and is largely preventable with decorin
treatment [10, 12, 57–64]. Although white matter abnormalities discovered were similar to those in hydrocephalic children [29–34], decorin was only able to protect
the internal capsule from myelin damage. TGF-β mediated signaling promotes central nervous system myelination by enhancing oligodendrocyte progenitor cell
differentiation and maturation [65, 66]. It is possible that
internal capsule oligodendrocyte progenitor cells may
be more susceptible to abnormalities in TGF-β signaling than those of the corpus callosum or periventricular
white matter, hence explaining the observed result.
The relationship between DTI parameters and cerebral
histopathological changes has been discussed extensively
in recent literature [27, 31, 32, 67–71]. Events that discourage directional water movement, such as interstitial
oedema and neurodegeneration cause a decline in the FA

AD

0.566

0.018*

0.409

0.103

FA
AD
RD

OX-42

FA
MD

0.729
0.903

0.159

0.541

−0.115

0.660

−0.485
0.647

0.048*
0.005*

AD

0.667

0.003*

0.680

0.003*

FA

−0.495
0.292

0.043*
0.256

AD

0.299

0.244

RD

0.213

0.411

FA

−0.640

MD
AD
MBP

0.091
−0.031

RD
MD

AQP4

0.205
0.462

RD
MD

Periventricular white GFAP
matter

0.191

0.006*

0.799 <0.001*
0.801 <0.001*

RD

0.829 <0.001*

FA

0.346

MD
AD
RD

−0.495

−0.360

−0.458

0.174
0.043*
0.155
0.064*

FA fractional anisotropy, MD mean diffusivity, AD axial diffusivity, RD radial
diffusivity, R the correlation coefficient
* Statistically significant correlations = p < 0.05

[27, 28, 72–77]. The AD and RD are two DTI parameters
that influence the FA and provide insight into axonal and
myelin integrity, respectively [73, 76]. Both the AD and
RD are also influenced by gliotic tissue changes [27, 72,
76]. Furthermore, an increase in average amount of diffusion in a given volume of tissue, caused by the presence of interstitial oedema or the loss of cellular barriers,
results in a rise in the MD [27, 77, 78].
Consistent with the results of Yuan et al. [41] in juvenile
rats with obstructive hydrocephalus, our findings in communicating hydrocephalus show positive correlations
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between GFAP increases and MD, AD, and RD in caudal periventricular white matter. Likewise, the increased
levels of OX-42 (a marker of microglia) correlated negatively with the FA. This result may seem surprising since
cytoarchitecturally in the periventricular white matter
of kaolin and kaolin + PBS rats, the majority of microglial processes were longitudinally oriented; therefore an
increase in FA would have been predicted [58]. However,
as others have reported in congenital hydrocephalus [64],
the cell bodies of reactive microglia in the periventricular white matter of our kaolin and kaolin + PBS animals
were enlarged and widened. This cytopathological characteristic may have obstructed the parallel diffusion of
water causing the FA to decrease. Since the pathophysiology of hydrocephalus is extremely multifactorial, it is
unlikely that glial alterations alone exert a causative effect
on DTI parameters.
The MBP levels of the caudal periventricular white
matter correlate with the MD. These results corroborate
the current literature; by increasing the volume of the
extracellular space, myelin disorganisation and demyelination increases the MD of water molecules [27, 73, 76].
In support of the Tourdias et al. [78] report on communicating hydrocephalus, AQP4 levels positively correlated
with the MD measurements in the caudal periventricular white matter. AQP4 levels also positively correlated
with the FA, RD and more interestingly the AD measurements. Although sparse literature exists on the relationship between AQP4 and AD, we suggest that the removal
of excess interstitial fluid by high levels of AQP4 may
promote the unobstructed parallel movement of water
through the periventricular white matter, hence resulting
in an increase in the AD measurement. Further investigation of this hypothesis needs to be undertaken in order to
substantiate such claim.
Here we have used kaolin to induce communicating hydrocephalus to help us determine the therapeutic
effects of decorin. It is important to recognize the possibility that some decorin-treated animals may not have
developed ventriculomegaly simply because of induction
failures. However, it is unlikely that a significant proportion of the decorin-treatment group would not develop
ventriculomegaly given the fact that 82 % of kaolin-only
or kaolin + PBS animals demonstrated significantly
enlarged ventricles [12]. In addition, 79 % of adult rats
with identical induction procedures developed ventriculomegaly [79]. Thus, we believe that the improvements
in the decorin-treated animals were due primarily to the
drug intervention. Another consideration of the study is
that the kaolin model of hydrocephalus is not the most
clinically relevant model, however it is the best characterised and most widely used, successfully replicating
the development and pathophysiological consequence
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of acquired hydrocephalus. Kaolin induces an inflammatory response with concomitant deposition of fibrosis
in areas of the subarachnoid space close to the injection site [80, 81] which is very similar to that observed
in subarachnoid haemorrhage rat models [82]. The
next step would be to determine the effects of decorin
in a post haemorrhagic model. Recently, Yan et al. [83]
demonstrated that pretreating rats with decorin in a
subarachnoid haemorrhage model led to a reduction
in ventriculomegaly and markers of fibrosis, indicating
that decorin may have beneficial effects in subarachnoid
haemorrhage. However further work needs to be conducted looking at the changes in cerebral cytopathology and microstructure with decorin treatment in this
model.

Conclusions
Our findings highlight the therapeutic potential of
decorin to attenuate hydrocephalus-induced changes in
astrogliosis, oedema and demyelination, particularly in
the caudal periventricular white matter. Our study also
helps to validate the use of DTI as a surrogate marker
of cytopathology in communicating hydrocephalus and
demonstrates that the caudal region of the brain appears
to be the most affected, showing the greatest changes in
ventriculomegaly, DTI and cytopathological measures in
our experimental model.
Additional files
Additional file 1: Figure S1. Decorin prevents ventriculomegaly
assessed by T2 weighted MRI images. A bar graph showing a significant increase in ventricular volume in hydrocephalic rats compared
to Intact controls. Furthermore, ventriculomegaly was prevented with
2.5 μg/0.5 µl/h infusion of human recombinant decorin treatment;
***p < 0.001. Corresponding representative T2- weighted MRI images
displaying the differences in ventricular volume between the experimental groups in the rostral and caudal brain. Arrows highlight the size of the
lateral ventricles (LV) or third ventricle (3V). Ventriculomegaly was evident
by MRI in the hydrocephalic rats but not in Intact controls or rats that
received decorin. Adapted from [12] with permission.
Additional file 2: Figue S2. DTI parameter abnormalities in the CA1
hippocampus, rostral and caudal internal capsule. Mean values + the
standard error of the means are displayed for the fractional anisotropy
(FA), mean diffusivity (MD), axial diffusivity (AD) and radial diffusivity
(RD) in the (A) outer parietal cortex, (B) inner parietal cortex, (C) CA1
hippocampus, (D) caudal internal capsule and (E) rostral internal capsule;
significant differences (p < 0.05) in the DTI parameter values from intact (*)
or kaolin + PBS (+) levels are presented.
Additional file 3: Table S1. In the corpus callosum, no significant cytopathological changes were observed in hydrocephalic animals. The mean
values ± the standard error of the means of GFAP, OX-42, AQP4 and MBP
immunostaining in the four different experimental groups are expressed.

Additional file 4: Table S2. AQP4, GFAP and OX-42 levels in the CA1 and
CA3 hippocampus, internal capsule, caudate-putamen, parietal cortex
and occipital cortex in the four experimental groups; values represent the
mean ± standard error of the means, * = p<0.05.
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Appendix 1
Diffusion tensor imaging (DTI). DTI is a specialised
magnetic resonance imaging technique that is used to
gain greater appreciation of white matter disease-related
pathophysiology via probing the random translational
motion of water molecules [26]. The scalar parameters
in DTI provide a quantitative method to assess cerebral
water motion by specifically examining the magnitude
and direction of water diffusion, which is quantified by
measuring key parameters such as axial diffusivity (AD),
radial diffusivity (RD) and their derivatives mean diffusivity (MD) or fractional anisotropy (FA). The FA values
provide insight into the anisotropy of water diffusion.
Water may diffuse isotropically, i.e. equally in all directions, or along a specific direction, therefore becoming
anisotropic in nature. Moreover, the FA can be influenced
by changes in microstructural integrity [27]; neurodegeneration and axonal reorganization hinders isotropic water
movement, decreasing the FA. Furthermore, in ventriculomegaly-induced cerebral compression, increased AQP4
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levels and gliosis raise the FA [74]. The RD and AD are
two parameters that directly influence the FA. In white
matter, the proportion of water diffusing perpendicular
to neuronal fibres is assessed by RD, whilst the degree
of water diffusion parallel to tract orientation is determined by the AD. Increased RD and AD are indicators
of myelin and axonal integrity, respectively. Both RD and
AD are also reported to increase upon astrogliosis [27].
Quantification of the average magnitude of diffusion in a
given volume of tissue is provided by the MD value. MD
is decreased by the presence of cellular barriers [80]. In
contrast, interstitial edema and greater AQP4 and microglial presence are responsible for a rise in the MD [80].
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